Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
- PMID: 10448305
- DOI: 10.1016/s0959-8049(98)00371-2
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
Abstract
The aim of this study was to assess the expression of cytokine transcripts, reflecting the type of ongoing immune responses at the site of human papillomavirus (HPV) infection, in relation to the development of cervical neoplasia. To this end reverse transcription-polymerase chain reaction (RT-PCR) was performed for interferon (IFN) gamma, interleukin (IL)-2, IL-4, IL-5, IL-10, IL-12 (p35 and p40), and transforming growth factor (TGF beta 1) in snap-frozen cervical biopsies, which were tested for the presence of high risk HPV DNA and histologically classified from normal to invasive carcinoma (n = 40). IFN gamma, IL-10 and IL-12 (p35 and p40) transcripts were found to be expressed at significantly lower frequencies in invasive carcinoma as compared with premalignant biopsies (P = 0.006, P = 0.007 and P = 0.002, respectively). IFN gamma IL-10 mRNA were associated with the presence of the IL-12 p35 and p40 transcripts (P = 0.008 and P < 0.00001, respectively). These results are consistent with a locally reduced cellular (type 1) immunity correlating with HPV-induced invasive cervical carcinoma.
Similar articles
-
Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer.J Pathol. 2001 Sep;195(2):179-85. doi: 10.1002/path.929. J Pathol. 2001. PMID: 11592096
-
Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ.Med Oncol. 2014 Sep;31(9):143. doi: 10.1007/s12032-014-0143-0. Epub 2014 Aug 9. Med Oncol. 2014. PMID: 25106529
-
Increased number of IL-2, IL-2 receptor and IL-10 positive cells in premalignant lesions of the cervix.Invest Clin. 2008 Dec;49(4):533-45. Invest Clin. 2008. PMID: 19245171
-
Our approach to squamous intraepithelial lesions of the uterine cervix.J Clin Pathol. 2007 May;60(5):449-55. doi: 10.1136/jcp.2005.036426. Epub 2006 Oct 17. J Clin Pathol. 2007. PMID: 17046846 Free PMC article. Review.
-
DNA methylation and detection of cervical cancer and precancerous lesions using molecular methods.Tumour Biol. 2016 Jan;37(1):23-7. doi: 10.1007/s13277-015-4197-1. Epub 2015 Oct 12. Tumour Biol. 2016. PMID: 26459314 Review.
Cited by
-
CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.J Clin Immunol. 2009 Jul;29(4):532-44. doi: 10.1007/s10875-009-9279-7. Epub 2009 Mar 4. J Clin Immunol. 2009. PMID: 19259799
-
Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development.J Oncol. 2012;2012:278312. doi: 10.1155/2012/278312. Epub 2011 Dec 19. J Oncol. 2012. PMID: 22220169 Free PMC article.
-
Cervical cancer and CYP2E1 polymorphisms: implications for molecular epidemiology.Eur J Clin Pharmacol. 2006 Jan;62(1):15-21. doi: 10.1007/s00228-005-0066-y. Epub 2005 Dec 22. Eur J Clin Pharmacol. 2006. PMID: 16372174
-
Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.Clin Dev Immunol. 2012;2012:785825. doi: 10.1155/2012/785825. Epub 2011 Oct 13. Clin Dev Immunol. 2012. PMID: 22013487 Free PMC article.
-
Diminished IFN-gamma and IL-10 and elevated Foxp3 mRNA expression in the cervix are associated with CIN 2 or 3.Int J Cancer. 2009 Mar 15;124(6):1379-83. doi: 10.1002/ijc.24117. Int J Cancer. 2009. PMID: 19089920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials